Cantillon Capital Management LLC decreased its stake in Agilent Technologies, Inc. (NYSE:A) by 4.0% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 5,013,259 shares of the medical research company’s stock after selling 211,000 shares during the period. Agilent Technologies comprises about 3.7% of Cantillon Capital Management LLC’s portfolio, making the stock its 13th largest position. Cantillon Capital Management LLC owned 1.56% of Agilent Technologies worth $297,337,000 as of its most recent filing with the SEC.
Other institutional investors have also added to or reduced their stakes in the company. Park National Corp OH boosted its position in Agilent Technologies by 1.1% in the second quarter. Park National Corp OH now owns 4,077 shares of the medical research company’s stock valued at $242,000 after buying an additional 43 shares during the last quarter. Trust Co. of Vermont boosted its stake in Agilent Technologies by 1.8% in the second quarter. Trust Co. of Vermont now owns 2,793 shares of the medical research company’s stock worth $166,000 after buying an additional 50 shares in the last quarter. Neuberger Berman Group LLC boosted its stake in Agilent Technologies by 0.9% in the first quarter. Neuberger Berman Group LLC now owns 9,840 shares of the medical research company’s stock worth $520,000 after buying an additional 91 shares in the last quarter. HL Financial Services LLC boosted its stake in Agilent Technologies by 1.1% in the second quarter. HL Financial Services LLC now owns 8,957 shares of the medical research company’s stock worth $531,000 after buying an additional 94 shares in the last quarter. Finally, Wetherby Asset Management Inc. boosted its stake in Agilent Technologies by 1.6% in the second quarter. Wetherby Asset Management Inc. now owns 6,124 shares of the medical research company’s stock worth $363,000 after buying an additional 97 shares in the last quarter.
Shares of Agilent Technologies, Inc. (NYSE:A) traded up 0.05% on Wednesday, hitting $62.99. The company’s stock had a trading volume of 167,073 shares. The company has a market cap of $20.28 billion, a price-to-earnings ratio of 32.49 and a beta of 1.30. Agilent Technologies, Inc. has a 52 week low of $42.92 and a 52 week high of $63.06. The stock’s 50 day moving average is $60.37 and its 200-day moving average is $56.33.
Agilent Technologies (NYSE:A) last issued its earnings results on Tuesday, August 15th. The medical research company reported $0.59 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.07. Agilent Technologies had a net margin of 14.36% and a return on equity of 16.95%. The firm had revenue of $1.11 billion during the quarter, compared to the consensus estimate of $1.09 billion. During the same quarter in the prior year, the firm earned $0.49 earnings per share. The business’s quarterly revenue was up 6.7% on a year-over-year basis. On average, equities research analysts anticipate that Agilent Technologies, Inc. will post $2.31 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Agilent Technologies, Inc. (A) Stake Reduced by Cantillon Capital Management LLC” was first reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of US and international trademark and copyright laws. The legal version of this story can be read at https://stocknewstimes.com/2017/08/23/agilent-technologies-inc-a-stake-reduced-by-cantillon-capital-management-llc.html.
A number of equities research analysts recently weighed in on the company. BidaskClub cut Agilent Technologies from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 12th. Janney Montgomery Scott upped their price target on Agilent Technologies from $65.00 to $70.00 and gave the stock a “buy” rating in a report on Wednesday, August 16th. J P Morgan Chase & Co restated an “overweight” rating and issued a $70.00 price target on shares of Agilent Technologies in a report on Wednesday, August 16th. Bank of America Corporation upped their price target on Agilent Technologies from $66.00 to $68.00 and gave the stock an “equal weight” rating in a report on Wednesday, August 16th. Finally, Jefferies Group LLC restated a “buy” rating and issued a $66.00 price target on shares of Agilent Technologies in a report on Wednesday, August 9th. Three equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. Agilent Technologies has a consensus rating of “Buy” and a consensus target price of $63.18.
In other news, Director Paul N. Clark sold 3,866 shares of the stock in a transaction on Thursday, May 25th. The shares were sold at an average price of $59.05, for a total transaction of $228,287.30. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Heidi Fields sold 8,625 shares of the stock in a transaction on Friday, June 16th. The stock was sold at an average price of $59.53, for a total transaction of $513,446.25. The disclosure for this sale can be found here. Insiders sold 145,099 shares of company stock valued at $8,927,003 in the last ninety days.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
